Novartis seeks European approval of cell therapy Kymriah

on November 6th, 2017, 6:46am
ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday it submitted an application for its cell therapy Kymriah to be approved in Europe for two forms of blood cancer.

More Health News

5 Nov 2017

Ryan says Obamacare mandate repeal on table in tax debate: Fox News Sunday

WASHINGTON (Reuters) - U.S. House speaker Paul Ryan said his colleagues might use the tax overhaul currently under consideration to repeal the Affordable Care Act provision that mandates individuals buy health insurance.

3 Nov 2017

Torrent Pharma to buy Unichem Labs' India business for $558 million

(Reuters) - Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.

3 Nov 2017

Former GSK boss to lead new UK accelerated drug access scheme

LONDON (Reuters) - Former GlaxoSmithKline boss Andrew Witty is to lead a new British scheme to accelerate access to ground-breaking medicines for conditions such as cancer, dementia and diabetes from April 2018, the government announced on Friday.

Top News Videos